Global Pneumonia Vaccine Market Research Report 2024
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Pneumococcal Conjugate Vaccine (PCV13)
Pneumococcal Polysaccharide Vaccine (PPSV23)
Other
Segment by Application
Pneumonia
Meningitis
Sepsis
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Pfizer Inc.
Glaxosmithkline Plc.
Merck & Co., Inc.
Sanofi Pasteur
Serum Institute of India Pvt. Ltd.
Johnson & Johnson
Astellas Pharma Inc.
Astrazeneca Plc.
CSL Limited
Emergent Biosolutions
Walvax Biotechnology
Royal (Wuxi) Bio-Pharmaceutical
Zhifei Biologic

Table of Content
1 Pneumonia Vaccine Market Overview
1.1 Product Overview and Scope of Pneumonia Vaccine
1.2 Pneumonia Vaccine Segment by Type
1.2.1 Global Pneumonia Vaccine Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Pneumococcal Conjugate Vaccine (PCV13)
1.2.3 Pneumococcal Polysaccharide Vaccine (PPSV23)
1.2.4 Other
1.3 Pneumonia Vaccine Segment by Application
1.3.1 Global Pneumonia Vaccine Sales Comparison by Application: (2021-2027)
1.3.2 Pneumonia
1.3.3 Meningitis
1.3.4 Sepsis
1.4 Global Pneumonia Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pneumonia Vaccine Revenue 2016-2027
1.4.2 Global Pneumonia Vaccine Sales 2016-2027
1.4.3 Pneumonia Vaccine Market Size by Region: 2016 Versus 2021 Versus 2027
2 Pneumonia Vaccine Market Competition by Manufacturers
2.1 Global Pneumonia Vaccine Sales Market Share by Manufacturers (2016-2021)
2.2 Global Pneumonia Vaccine Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Pneumonia Vaccine Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Pneumonia Vaccine Manufacturing Sites, Area Served, Product Type
2.5 Pneumonia Vaccine Market Competitive Situation and Trends
2.5.1 Pneumonia Vaccine Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Pneumonia Vaccine Players Market Share by Revenue
2.5.3 Global Pneumonia Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pneumonia Vaccine Retrospective Market Scenario by Region
3.1 Global Pneumonia Vaccine Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Pneumonia Vaccine Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Pneumonia Vaccine Market Facts & Figures by Country
3.3.1 North America Pneumonia Vaccine Sales by Country
3.3.2 North America Pneumonia Vaccine Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Pneumonia Vaccine Market Facts & Figures by Country
3.4.1 Europe Pneumonia Vaccine Sales by Country
3.4.2 Europe Pneumonia Vaccine Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Pneumonia Vaccine Market Facts & Figures by Region
3.5.1 Asia Pacific Pneumonia Vaccine Sales by Region
3.5.2 Asia Pacific Pneumonia Vaccine Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Pneumonia Vaccine Market Facts & Figures by Country
3.6.1 Latin America Pneumonia Vaccine Sales by Country
3.6.2 Latin America Pneumonia Vaccine Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Pneumonia Vaccine Market Facts & Figures by Country
3.7.1 Middle East and Africa Pneumonia Vaccine Sales by Country
3.7.2 Middle East and Africa Pneumonia Vaccine Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Pneumonia Vaccine Historic Market Analysis by Type
4.1 Global Pneumonia Vaccine Sales Market Share by Type (2016-2021)
4.2 Global Pneumonia Vaccine Revenue Market Share by Type (2016-2021)
4.3 Global Pneumonia Vaccine Price by Type (2016-2021)
5 Global Pneumonia Vaccine Historic Market Analysis by Application
5.1 Global Pneumonia Vaccine Sales Market Share by Application (2016-2021)
5.2 Global Pneumonia Vaccine Revenue Market Share by Application (2016-2021)
5.3 Global Pneumonia Vaccine Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Pfizer Inc.
6.1.1 Pfizer Inc. Corporation Information
6.1.2 Pfizer Inc. Description and Business Overview
6.1.3 Pfizer Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Pfizer Inc. Pneumonia Vaccine Product Portfolio
6.1.5 Pfizer Inc. Recent Developments/Updates
6.2 Glaxosmithkline Plc.
6.2.1 Glaxosmithkline Plc. Corporation Information
6.2.2 Glaxosmithkline Plc. Description and Business Overview
6.2.3 Glaxosmithkline Plc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Glaxosmithkline Plc. Pneumonia Vaccine Product Portfolio
6.2.5 Glaxosmithkline Plc. Recent Developments/Updates
6.3 Merck & Co., Inc.
6.3.1 Merck & Co., Inc. Corporation Information
6.3.2 Merck & Co., Inc. Description and Business Overview
6.3.3 Merck & Co., Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Merck & Co., Inc. Pneumonia Vaccine Product Portfolio
6.3.5 Merck & Co., Inc. Recent Developments/Updates
6.4 Sanofi Pasteur
6.4.1 Sanofi Pasteur Corporation Information
6.4.2 Sanofi Pasteur Description and Business Overview
6.4.3 Sanofi Pasteur Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Sanofi Pasteur Pneumonia Vaccine Product Portfolio
6.4.5 Sanofi Pasteur Recent Developments/Updates
6.5 Serum Institute of India Pvt. Ltd.
6.5.1 Serum Institute of India Pvt. Ltd. Corporation Information
6.5.2 Serum Institute of India Pvt. Ltd. Description and Business Overview
6.5.3 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Serum Institute of India Pvt. Ltd. Pneumonia Vaccine Product Portfolio
6.5.5 Serum Institute of India Pvt. Ltd. Recent Developments/Updates
6.6 Johnson & Johnson
6.6.1 Johnson & Johnson Corporation Information
6.6.2 Johnson & Johnson Description and Business Overview
6.6.3 Johnson & Johnson Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Johnson & Johnson Pneumonia Vaccine Product Portfolio
6.6.5 Johnson & Johnson Recent Developments/Updates
6.7 Astellas Pharma Inc.
6.6.1 Astellas Pharma Inc. Corporation Information
6.6.2 Astellas Pharma Inc. Description and Business Overview
6.6.3 Astellas Pharma Inc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Astellas Pharma Inc. Pneumonia Vaccine Product Portfolio
6.7.5 Astellas Pharma Inc. Recent Developments/Updates
6.8 Astrazeneca Plc.
6.8.1 Astrazeneca Plc. Corporation Information
6.8.2 Astrazeneca Plc. Description and Business Overview
6.8.3 Astrazeneca Plc. Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Astrazeneca Plc. Pneumonia Vaccine Product Portfolio
6.8.5 Astrazeneca Plc. Recent Developments/Updates
6.9 CSL Limited
6.9.1 CSL Limited Corporation Information
6.9.2 CSL Limited Description and Business Overview
6.9.3 CSL Limited Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.9.4 CSL Limited Pneumonia Vaccine Product Portfolio
6.9.5 CSL Limited Recent Developments/Updates
6.10 Emergent Biosolutions
6.10.1 Emergent Biosolutions Corporation Information
6.10.2 Emergent Biosolutions Description and Business Overview
6.10.3 Emergent Biosolutions Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.10.4 Emergent Biosolutions Pneumonia Vaccine Product Portfolio
6.10.5 Emergent Biosolutions Recent Developments/Updates
6.11 Walvax Biotechnology
6.11.1 Walvax Biotechnology Corporation Information
6.11.2 Walvax Biotechnology Pneumonia Vaccine Description and Business Overview
6.11.3 Walvax Biotechnology Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.11.4 Walvax Biotechnology Pneumonia Vaccine Product Portfolio
6.11.5 Walvax Biotechnology Recent Developments/Updates
6.12 Royal (Wuxi) Bio-Pharmaceutical
6.12.1 Royal (Wuxi) Bio-Pharmaceutical Corporation Information
6.12.2 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Description and Business Overview
6.12.3 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.12.4 Royal (Wuxi) Bio-Pharmaceutical Pneumonia Vaccine Product Portfolio
6.12.5 Royal (Wuxi) Bio-Pharmaceutical Recent Developments/Updates
6.13 Zhifei Biologic
6.13.1 Zhifei Biologic Corporation Information
6.13.2 Zhifei Biologic Pneumonia Vaccine Description and Business Overview
6.13.3 Zhifei Biologic Pneumonia Vaccine Sales, Revenue and Gross Margin (2016-2021)
6.13.4 Zhifei Biologic Pneumonia Vaccine Product Portfolio
6.13.5 Zhifei Biologic Recent Developments/Updates
7 Pneumonia Vaccine Manufacturing Cost Analysis
7.1 Pneumonia Vaccine Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Pneumonia Vaccine
7.4 Pneumonia Vaccine Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Pneumonia Vaccine Distributors List
8.3 Pneumonia Vaccine Customers
9 Pneumonia Vaccine Market Dynamics
9.1 Pneumonia Vaccine Industry Trends
9.2 Pneumonia Vaccine Growth Drivers
9.3 Pneumonia Vaccine Market Challenges
9.4 Pneumonia Vaccine Market Restraints
10 Global Market Forecast
10.1 Pneumonia Vaccine Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Pneumonia Vaccine by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Pneumonia Vaccine by Type (2022-2027)
10.2 Pneumonia Vaccine Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Pneumonia Vaccine by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Pneumonia Vaccine by Application (2022-2027)
10.3 Pneumonia Vaccine Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Pneumonia Vaccine by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Pneumonia Vaccine by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer